I think it’s going according to plan. Leo said...”Patient enrollment in the Phase 2 study of Brilacidin for COVID-19 is moving along quickly, far faster in recruitment than other COVID-19 studies we’ve seen in industry reports.”
Even if recruitment is done by the end of may there’s another month to go. Unfortunately!